Welsis Corp.
WLSS
$2.90
-$0.09-3.01%
Weiss Ratings | WLSS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | WLSS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Weak | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | WLSS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -- | |||
Price History | WLSS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -4.61% | |||
30-Day Total Return | 36.79% | |||
60-Day Total Return | 38.10% | |||
90-Day Total Return | 145.76% | |||
Year to Date Total Return | 130.16% | |||
1-Year Total Return | -- | |||
2-Year Total Return | -- | |||
3-Year Total Return | -- | |||
5-Year Total Return | -- | |||
52-Week High % Change | -45.74% | |||
52-Week Low % Change | 389.20% | |||
Price | WLSS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $5.51 | |||
52-Week Low Price | $0.61 | |||
52-Week Low Price (Date) | Oct 09, 2024 | |||
52-Week High Price (Date) | Oct 02, 2024 | |||
Valuation | WLSS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 8.23M | |||
Enterprise Value | 8.30M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.01 | |||
Earnings Per Share Growth | -20.25% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | -- | |||
Price/Book (Q) | -72.22 | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $2.90 | |||
Enterprise Value/EBITDA (TTM) | -- | |||
Enterprise Value/EBIT | -122.39 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | WLSS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 2.75M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | WLSS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 215 552 8991 | |||
Address | 701 E Cathedral Road Philadelphia, PA 19128 | |||
Website | -- | |||
Country | United States | |||
Year Founded | 2021 | |||
Profitability | WLSS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | WLSS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -316.23% | |||
Return on Equity | -- | |||
Income Statement | WLSS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 0.00 | |||
Total Revenue (TTM) | 0.00 | |||
Revenue Per Share | $0.00 | |||
Gross Profit (TTM) | 0.00 | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -67.80K | |||
Net Income (TTM) | -35.70K | |||
Net Income Avl. to Common (TTM) | -35.70K | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | -82.71% | |||
EPS Diluted (TTM) | -0.01 | |||
EPS Diluted Growth (Q YOY) | -83.33% | |||
Balance Sheet | WLSS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | -- | |||
Cash Per Share (Q) | -- | |||
Total Current Assets (Q) | 4.10K | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | -113.90K | |||
Current Ratio (Q) | 0.045 | |||
Book Value Per Share (Q) | -$0.04 | |||
Total Assets (Q) | 4.10K | |||
Total Current Liabilities (Q) | 90.80K | |||
Total Debt (Q) | 67.20K | |||
Total Liabilities (Q) | 118.00K | |||
Total Common Equity (Q) | -113.90K | |||
Cash Flow | WLSS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 21.30K | |||
Cash from Financing (TTM) | 6.30K | |||
Net Change in Cash (TTM) | -1.40K | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -29.00K | |||